News

Body Dysmorphic Disorder Criteria May Expand in DSM-5


 

FROM THE ANNUAL MEETING OF THE AMERICAN COLLEGE OF PSYCHIATRISTS

SSRI augmentation could be considered. Small case series suggest that buspirone might be an effective augmentation agent at average doses of 50-60 mg/day, she said. Minimal data on antipsychotics to augment SSRI therapy mostly suggest that antipsychotics are not helpful, though some clinical experience hints at a possible role for atypicals.

Other augmenting agents that have shown some promise in limited reports include clomipramine, venlafaxine, lithium, and levetiracetam. Stimulants also have had positive results.

Dr. Phillips said she has received donated medications for studies from Forest Laboratories. She also reported receiving royalties from three publishers: The Free Press, Guilford Press, and Oxford University Press.

Pages

Recommended Reading

Techniques Compared for Breast Tumor Detection
MDedge Internal Medicine
Clinical Trial Participation Tied to Improved Breast Cancer Outcomes
MDedge Internal Medicine
HIV Prevention, Testing of Nonpregnant Women
MDedge Internal Medicine
Makena Price Spike Causes Anger, Fear
MDedge Internal Medicine
Bone Micrometastases Show No Survival Impact in Early Breast Cancer
MDedge Internal Medicine
NCCN Breast Guidelines Stand by Bevacizumab
MDedge Internal Medicine
Tryptophan, Tyrosine May Battle Early Postpartum Depression
MDedge Internal Medicine
Treating Mood Disorders in Pregnancy – Not an Easy Decision
MDedge Internal Medicine
Vocal Cord Dysfunction More Common in Certain Groups
MDedge Internal Medicine
Thin Endometrial Echo Complex Does Not Rule Out Cancer
MDedge Internal Medicine